Evidence map›Paper›PMID 25405151›Full record

ArticleAnnals of translational medicine2014

Chemically defined serum-free and xeno-free media for multiple cell lineages.

Sümeyra Naz Usta, Christopher D Scharer, Jie Xu, Teryl K Frey, Rodney J Nash

Abstract read
In one paragraph

Article in Annals of translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Secretomics to Discover Regulators in Diseases.International journal of molecular sciences · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sümeyra Naz Usta1 Jeevan Biosciences Inc., Dunwoody, GA, USA ; 2 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA ; 3 Department of Biology, Georgia State University, Atlanta, GA, USA.
Christopher D Scharer1 Jeevan Biosciences Inc., Dunwoody, GA, USA ; 2 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA ; 3 Department of Biology, Georgia State University, Atlanta, GA, USA.
Jie Xu1 Jeevan Biosciences Inc., Dunwoody, GA, USA ; 2 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA ; 3 Department of Biology, Georgia State University, Atlanta, GA, USA.
Teryl K Frey1 Jeevan Biosciences Inc., Dunwoody, GA, USA ; 2 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA ; 3 Department of Biology, Georgia State University, Atlanta, GA, USA.
Rodney J Nash1 Jeevan Biosciences Inc., Dunwoody, GA, USA ; 2 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA ; 3 Department of Biology, Georgia State University, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell culture is one of the most common methods used to recapitulate a human disease environment in a laboratory setting. Cell culture techniques are used to grow and maintain cells of various types including those derived from primary tissues, such as stem cells and cancer tumors. However, a major confounding factor with cell culture is the use of serum and animal (xeno) products in the media. The addition of animal products introduces batch and lot variations that lead to experimental variability, confounds studies with therapeutic outcomes for cultured cells, and represents a major cost associated with cell culture. Here we report a commercially available serum-free, albumin-free, and xeno free (XF) media (Neuro-Pure(TM)) that is more cost-effective than other commercial medias. Neuro-Pure was used to maintain and differentiate various cells of neuronal lineages, fibroblasts, as well as specific cancer cell lines; without the use of contaminants such serum, albumin, and animal products. Neuro-Pure allows for a controlled and reproducible cell culture environment that is applicable to translational medicine and general tissue culture.

Indexed as

cell mediadrug-developmentSerum-freestem cellsxeno free (XF)

Identifiers

PMID25405151
PMCPMC4205861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.